As controversy over the safety of the


vaccine arose, Sweden temporarily suspended the Janssen vaccination, and Denmark stopped using the AstraZeneca vaccine for the first time in the world.

The European Medicines Agency is due to release the results of the Janssen vaccine's safety evaluation sometime next week.

Reporter Kang Cheong-wan reports.

<Reporter> The

European Medicines Agency announced that the Safety Committee is currently reviewing cases of thrombotic reactions from Janssen vaccination and will announce the results of the review sometime next week.

Vaccination policies in European countries are also expected to diverge for the time being until the results come out.

Swedish health officials have temporarily suspended the Corona 19 Janssen vaccination plan until the release of the European Medicines Agency.

France, on the other hand, says it will continue to maintain its existing policy of vaccinating people over the age of 55 with the Janssen vaccine.

[Gabriel Atal/French Government Spokesperson: Authorized by the authorities, the Janssen vaccine will be vaccinated under the same conditions as the AstraZeneca vaccine.

It is intended for people over the age of 55.] Although

the first shipments of Janssen vaccine produced in the United States have been arriving several days ago in European countries, the vaccination is delayed as the US authorities recommend discontinuing the use of the Janssen vaccine due to the occurrence of thrombotic side effects. is.

In the meantime, the White House said that even if Janssen vaccination was stopped, it would have already secured 600 million doses of Pfizer and modder vaccines, so that there would be no disruption to the vaccination plan.

There is growing concern that the vaccination crisis in the international community will worsen as the use of the Janssen vaccine is put to a brake on the vaccination trend toward certain countries such as the United States.